A new dose for eliglistat (Cerdelga) – reasoning
In the previous topic we learned that the proposed dose regimen of eliglustat depends on the CYP2D6 metabolizer status.
Please login or signup for this course to get access.
In the previous topic we learned that the proposed dose regimen of eliglustat depends on the CYP2D6 metabolizer status.
Please login or signup for this course to get access.